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ABSTRACT 39 
 40 
Background  41 
Synthetic biology is an emerging multidisciplinary area of research with potential to deliver 42 
various novel agrifood applications. Its long-term adoption and commercialisation will 43 
depend on the extent to which the public accept synthetic biology and its different 44 
applications. 45 
Scope and approach  46 
A mapping review of existing research on public perceptions of, and attitudes towards, 47 
synthetic biology and its applications to agriculture and food production was conducted. This 48 
enabled an overall overview of current knowledge about  public perceptions and attitudes to 49 
be developed, and current research gaps to be identified.  50 
Key findings and conclusions  51 
Although some risk-related and ethical concerns were raised by the public, there was little 52 
evidence showing that people had an inherently negative perception of synthetic biology. The 53 
results demonstrated the importance of perceived benefits, perceived risks and ethical issues 54 
in shaping public acceptance of synthetic biology applied to agrifood production. Where 55 
analysis focused on specific applications, and people tended to be more positive about 56 
medical and environmental applications compared to those in the agrifood sector, an effect 57 
which has also been found in other areas of technology application. However, at present, the 58 
literature is focused on synthetic biology as an enabling technology rather than on its specific 59 
applications. Given that there is some evidence that people’s attitudes varied by product 60 
types, more research on specific applications is therefore needed to further investigate public 61 
attitudes and co-develop societal preferences for agrifood products. 62 
Key words: Synthetic biology, Food, Agriculture, Public perception, Public attitude; 63 
Mapping review. 64 
 65 
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 70 
1. Introduction  71 
Synthetic biology is a novel multidisciplinary area of research that has been the focus of 72 
considerable attention in academia due to its numerous potential applications across different 73 
domains (e.g. in medicine, material science and agriculture, inter alia) (Benner & Sismour, 74 
2005). In common with other emerging technologies, such as nanotechnology, there is no 75 
standardised definition available to date. The European Commision (2005) has defined 76 
syntheic biology as “applying the engineering paradigm of systems design to biological 77 
systems in order to produce predictable and robust systems with novel functionalities that do 78 
not exist in nature” (p. 10). The Royal Academy of Engineering (2009) has proposed that 79 
synthetic biology involves “the design and construction of novel artificial biological 80 
pathways, organisms and devices, or the redesign of existing natural biological systems” (p. 81 
13). Alternatively synthetic biology can be described as “the design and construction of new 82 
biological parts, devices, and systems, and the redesign of existing, natural biological systems 83 
for useful purposes” (Springer Nature, 2019). All definitions encompass the notion that 84 
applications of synthetic biology involve the creation of novel living systems through 85 
synthesising and assembling artificial and/or natural components.  86 
There are both technology and application differences between synthetic biology and genetic 87 
modification (GM). Synthetic biology constructs living systems by synthesising and 88 
assembling DNA according to engineering principles (Cameron, Bashor, & Collins, 2014), 89 
whilst GM simply inserts a piece of foreign DNA into host organisms to produce desired 90 
traits (Colwell, Norse, Pimentel, Sharples, & Simberloff, 1985). Consequently, synthetic 91 
biology could involve the use of much larger amounts of DNA, either that which is naturally 92 
occurring or synthetic, and the constructed parts could be standardised and shared within the 93 
community to establish more complex living systems (Cameron et al., 2014). The sharing and 94 
rebuilding based on standardised living systems could facilitate the development of new 95 
applications, but may simultaneously increase the risks of releasing synthetic biological 96 
agents into the environment (Polizzi, Stanbrough, & Heap, 2018). A serious challenge for 97 
scientists and policy-makers can be identified in relation to risk assessment and governance,  98 
as the complexity of synthetic biology-based applications constantly grows, including those 99 
within the agrifood sector (Pauwels et al., 2013). In addition, the “bottom-up” approach of 100 
synthetic biology, which  aims to create artificial or semi-artificial life de novo, has evoked 101 
strong ethical controversy (Bedau, Parke, Tangen, & Hantsche-Tangen, 2009). Ethical 102 
4 
 
concern can Thus, it is important to investigate public perceptions of, attitudes towards 103 
synthetic biology separately rather than intermingle the two technologies. 104 
At present, around 700 organizations are engaged in synthetic biology-related research across 105 
40 countries; and more than 350 companies have been established which apply synthetic 106 
biology as part of their activities. the global market value of these companies estimated to be 107 
$3.9 billion in 2016 (Bueso & Tangney, 2017). A number of applications have been 108 
developed for use within the agrifood sector (Table 1). However, future commercialisation of 109 
these applications could be uncertain due to societal concerns about potential risks and ethical 110 
issues (Polizzi et al., 2018). Companies which align their products with consumer preferences 111 
and priorities may gain commercial success (Raley, Ragona, Sijtsema, Fischer, & Frewer, 112 
2016). In this context, the present study attempts to review the existing literature for 113 
understanding public perceptions and attitudes regarding synthetic biology, including  those 114 
linked to agrifood applications. In addition, we attempt to compare the results with research 115 
on other emerging technologies, such as GM and nanotechnology, to identify differences and 116 
similarities in perceptions and attitudes, and to assess whether it is possible to learn how best 117 
to commercialise different applications of synthetic biology from applications of other 118 
enabling technologies in the agrifood sector.  (see Frewer et al., 2011). 119 
This paper therefore aims to address the following questions:  120 
• Are there specific issues raised that distinguish synthetic biology from other enabling 121 
agri-technologies regarding public concerns?  122 
• What factors may potentially affect the public’s perceptions of, and attitudes towards, 123 
synthetic biology and its applications?  124 
• What applications might the public and/or consumers prefer to be developed and 125 
commercialised within the agrifood sector? 126 
This information will provide knowledge of direct relevance to those with interests in 127 
applying synthetic biology in the agrifood sector, in particular in relation to which 128 
applications can be developed, how products should be designed, and how governance can be 129 
optimised in the light of public and environmental health as well as societal preferences 130 
(Frewer et al., 2011).   131 
 132 
 Methodology 133 
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This paper applied  a mapping review methodology to answer the proposed research 134 
questions by analysing and integrating existing research findings, while  simultaneously 135 
identifying  current knowledge gaps (Grant & Booth, 2009). The relevant  literature was 136 
identified  using a two-stage search strategy between 1st July and 30th October 2018. In the 137 
first stage, 3 databases (Scopus, Web of Science and ProQuest) were searched to retrieve 138 
literature published between January 2004 and December 2018. The terms, (a) “synthetic 139 
biology”;(b) “attitude”; (c) “perception”; (c) “media coverage”;  and (d) “press coverage” 140 
were used, in which (a) was separately combined with the other keywords. The returned 141 
references were screened and literature that was technical, (i.e. which discussed the process 142 
and application of synthetic biology as a scientific process), unempirical, in languages other 143 
than English, or “misunderstood” the concept of synthetic biology (for example, equating it 144 
with genetic modification) were  excluded. In the second stage, additional references were 145 
obtained from the reference list of eligible studies identified in the first stage. A total of 24 146 
studies were included, of which 8 were focused on an analysis of media reporting of synthetic 147 
biology, and 16 were empirically-based public attitudes related research. A comparison of the 148 
retrieved studies was conducted, which focused on their methods used and research findings 149 
to address the proposed research questions. The methodology therefore aligns with the 150 
criteria proposed for a “mapping review”, as proposed by Grant and Booth, 2009.  151 
2. Benefits, risks and ethical issues of synthetic biology-based agrifood applications 152 
There is evidence to suggest that emerging technologies have the potential to establish new 153 
industries or transform existing ones, delivering both benefits and risks (e.g. human health, 154 
environmental and socio-economic impacts) (Myers, 2007). These all need to be considered 155 
during their development and implementation processes, and integrated into the regulatory 156 
framework for technological governance. Previous studies have shown  that benefit and risk 157 
perceptions and attitudes drive societal acceptance of innovative food technologies, such as 158 
GM (Frewer et al., 2013) and nanotechnology (Giles, Kuznesof, Clark, Hubbard, & Frewer, 159 
2015). Specifically, different trade-offs between perceived potential risks, benefits and other 160 
issues could be made during people’s decision-making (Bearth & Siegrist, 2016; Hu, 161 
Hünnemeyer, Veeman, Adamowicz, & Srivastava, 2004; Mather et al., 2012).  This may also 162 
occur in  the context of public decision making associated with synthetic biology (Akin et al., 163 
2017; Pauwels, 2013). 164 
The technical advances (for example. new/cheaper ways of DNA synthesis and tools for 165 
DNA assembly) and more open sourcing (for example. circulation of foundational tools and 166 
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reusable synthetic parts) of synthetic biology have facilitated development of applications in 167 
different sectors, such as healthcare, energy, environment and agrifood. It is anticipated that 168 
these applications can provide new and cost-effective ways of disease treatment, drug and 169 
clean energy production, waste recycling, environment enhancement, among many others 170 
(Polizzi et al., 2018). Within the agrifood sector, synthetic biology offers better ways to 171 
improve crops, control pests and crop diseases, enhance the environment and manage 172 
livestock. It also has potential to deliver advantages to novel food and food ingredient 173 
production, food processing, food safety diagnosis, food waste processing and food 174 
packaging development (Table 1).  175 
……………………… 176 
Insert Table 1 here 177 
……………………… 178 
Despite the potential benefits, multiple risk issues have also been raised in relation to health, 179 
environmental, socioeconomic, and ethical impacts of synthetic biology. It is sometimes 180 
difficult to make precise risk calculations as the occurrence and consequences of a risk are 181 
associated with uncertainty (Rosa, 1998). This may indeed be the case for synthetic biology 182 
applied in the agrifood sector. For example, novel foods or food ingredients derived from 183 
synthetic organisms may be linked to public concerns about the uncertainties associated with 184 
their long-term impacts on human health, including  increased allergenicity, as has been the 185 
case with GM and other novel foods (van Putten et al., 2006). The release of synthetic 186 
microbes or plants may have adverse environmental impacts through affecting other natural 187 
species, and subsequently cause negative impacts on human health after entering the food 188 
system (Polizzi et al., 2018). An example is the use of synthetic gene-drive system to distort 189 
the sex-ratio of target pests, thereby reducing their ability to reproduce. Given the possibility 190 
of this system irreversibly entering other species, and the choice of insects as hosts, the 191 
application could be highly uncontrollable once released to the environment and subsequently 192 
damage the ecosystem more generally (Oye et al., 2014). In addition, upgraded techniques 193 
and open source platforms of synthetic biology make it easier to establish biological agents 194 
by people within or outside research institutes. It increases the  possibility of intended (e.g. 195 
“bioterror”) and unintended (i.e. “bioerror”) release of dangerous biological agents (Polizzi et 196 
al., 2018), and may in turn affect the perceived and actual potential for adverse effects on 197 
human health and environment.  198 
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Socioeconomic risks in relation to synthetic biology could also occur. For example, novel 199 
applications may negatively impact existing supply chains, within which stakeholders might 200 
suffer from negative economic consequences. The antimalarial drug (artemisinin) production 201 
by synthetic yeast might help stabilize the drug supply and decrease the cost, but traditional 202 
producers growing Artemisia annua for artemisinin extraction may be put out of business 203 
(Polizzi et al., 2018). Or the unbalanced adoption of synthetic biology-based agrifood 204 
applications, such as excessive growth of energy crops, may pose threats to food security if 205 
competition with food crops results (Harvey & Pilgrim, 2011). Ethical issues have also been 206 
frequently studied by ethics experts, in particular the raised concern about “playing God” or 207 
“tampering with nature” (Rogers, 2011). The potential for secondary use or misuse, together 208 
with other issues such as bioerror, bioterror, patent management, benefit distribution, 209 
research integrity, and regulations, have also been identified due to potentially negative 210 
consequences (Newson, 2015; Rogers, 2011).  211 
3. Media portrayal of synthetic biology  212 
In contrast to technical assessment of risks and benefits, public responses to emerging 213 
technologies could be highly context-dependent, for instance, influenced by risk framing and 214 
market interaction (Falk & Szech, 2013; Kahneman & Tversky, 1984). Kasperson et al. 215 
(1988) suggest that social context, such as the information transfer system and response 216 
mechanisms of society, could lead to social amplification or attenuation of risk, resulting in 217 
behavioural responses. GM foods, for example, were presented as hazardous in a crisis 218 
context by the British media, which subsequently “amplified” or increased peoples’ risk 219 
perceptions and negative attitudes (Frewer, Miles, & Marsh, 2002). It is possible that a 220 
similar effect may be observed for  synthetic biology, insomuch as the way in which it is 221 
portrayed in the media may also affect public attitudes, in particular given that people know 222 
little about it at the current time (Kinder & Robbins, 2018; Oliver, 2018).  223 
A body of literature exists which has focused on American and European media portrayals of 224 
synthetic biology, and has covered the period between 2003 and 2016. Themes, metaphors 225 
and tones of media reportage were analysed mainly using qualitative and quantitative content 226 
analysis (see Table 2). The coverage of synthetic biology has substantially increased in 227 
recent years (Ancillotti, Holmberg, Lindfelt, & Eriksson, 2017; Pauwels, Lovell, & Rouge, 228 
2012). However, the focus of existing articles was more associated with prominent events 229 
rather than potential risks and benefits of synthetic biology given thehe large increase of 230 
reportage occurred in 2008 and 2010 (Pauwels & Ifrim, 2008; Pauwels et al., 2012), 231 
8 
 
underpinned by events related to elite scientists’ visons  (J. Craig Venter Institute, 2008) and 232 
significant technical advance (Gibson et al., 2010). With respect to the identified coverage 233 
concerns, American and European media mainly presented bioerror, bioterror and ethical 234 
issues, of which ethical concerns was a greater focus in Europe, and bioerror in America 235 
(Pauwels, Lovell, & Rouge, 2012). Benefits of potential applications in healthcare, energy 236 
and environmental sectors were also introduced. Overall, media coverages describing only 237 
benefits, or balanced benefits and risks, outnumbered those underlining risk or ethical issues 238 
in both Europe and America (Ancillotti et al., 2017; Pauwels & Ifrim, 2008; Pauwels et al., 239 
2012).  240 
Metaphors applied in synthetic biology related coverage were also studied. The results 241 
showed that the frequency of  “religious” metaphors, such as “playing God” and “creating 242 
life”, is substantially lower than engineering and information technology related metaphors 243 
(Ancillotti & Eriksson, 2015; Ancillotti et al., 2017; Borgers, 2017; Braun, Fernau, & 244 
Dabrock, 2018). Hellsten and Nerlich (2011) argued that engineering-related metaphors 245 
might suggest the controllability of applications and potentially reduce readers’ perceived 246 
risks. In addition, tone of published stories in the European media were categorised according 247 
to their normative impression (Ancillotti & Eriksson, 2015; Ancillotti et al., 2017; Borgers, 248 
2017). Those highlighting benefits, or with an overall “approving” atone were assigned to 249 
“positive”, and media coverage objectively introducing benefits and risks without value 250 
judgement were regarded as “neutral”. Media reportage that portrayed synthetic biology as a 251 
negative development associated with negative implications was labelled as “negative”. The 252 
findings overall suggested  that the percentage of neutral or/and positive coverages was much 253 
higher than negative ones in European media (Ancillotti & Eriksson, 2015; Ancillotti et al., 254 
2017; Borgers, 2017). 255 
……………………… 256 
Insert Table 2 here 257 
……………………… 258 
Taken together, the current media reporting about synthetic biology appears not to amplify 259 
public risk perceptions or increase their negative attitudes. It is possible that the potential for 260 
healthcare and energy applications introduced by the media might trigger public interest in 261 
synthetic biology. However, several issues associated with media coverage still need to be 262 
considered. For example, synthetic biology may have been “over-promoted” in terms of what 263 
it can potentially deliver, at least in the short term. . This might decrease public trust in 264 
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synthetic biology and associated research programmes, impeding its future development 265 
(Ancillotti, Rerimassie, Seitz, & Steurer, 2016). Verseux et al. (2016) have  attributed the 266 
“hype” and presentation of far-future scenarios in the media to the lack of understandable 267 
documents about the current state of technological development which are targeted at non-268 
biologists. Another issue relates to the demand for clarity in defining and framing synthetic 269 
biology, which, once met, may facilitate public engagement and risk communication 270 
(Ancillotti et al., 2017; Giordano & Chung, 2018). As a result, better communication between 271 
academia and the media community is required to help develop clearer framing of synthetic 272 
biology and conduct effective science communication to the public in the light of specific 273 
applications and their current state of development.  274 
4. Public perceptions of and attitudes towards synthetic biology per se 275 
Research on public responses to synthetic biology has been relatively infrequent and mainly 276 
conducted in Europe and America (see Table 3). Participants often made sense of synthetic 277 
biology by comparing it with GM technology, while, for example,  nanotechnology has been 278 
less frequently  mentioned in public perception and attitude research as a “comparator” 279 
technology from a public perspective  (Kronberger, Holtz, Kerbe, Strasser, & Wagner, 2009; 280 
Kronberger, Holtz, & Wagner, 2012). Despite the ambiguous information about synthetic 281 
biology presented to research participants, another potential expalnation is that the two 282 
technologies may be both perceieved to involve deliberate changes to cells at the genetic 283 
level. Consequently, public concerns about synthetic biology were expressed in a similar way 284 
to those associated  to GM, although synthetic biology sometimes was perceived more 285 
negativly as people regarded it as a technological “upgrade” of GM (Steurer, 2015). In 286 
existing studies, people are mainly concerned about potential risks (e.g. potential 287 
environmental and health impacts, bioterror), moral, emotional or value-related issues (e.g. 288 
“unnaturalness”, “creating life” and “playing God”) and increased control of technology and 289 
patents by large companies (Betten, Broerse, & Kupper, 2018; Hart Research Associates, 290 
2013; Mandel, Braman, & Kahan, 2008). The public distrust of major stakeholder groups 291 
(e.g. scientists, industry and government) was also identified in research (Betten et al., 2018). 292 
However, more optimism was expressed by research participants regarding applications 293 
benefiting human health, energy and environment (Betten et al., 2018; Pauwels, 2009). 294 
……………………… 295 
Insert Table 3 here 296 
……………………… 297 
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Individual attitudes towards synthetic biology were not only associated with their risk and 298 
benefit perceptions, but also “value predispositions” (e.g. religiosity and deference towards 299 
scientific authority) and trust in scientists (Akin et al., 2017). Deference towards scientific 300 
authority represents the long-term and stable belief that scientific enterprise focuses on the 301 
best interests of the public, which is correlated with individual’s support for other 302 
technologies such as nanotechnology (Anderson, Scheufele, Brossard, & Corley, 2012). Trust 303 
in scientists has been defined as the short-term amd individual confidence in scientists’ 304 
motivation and competency (Akin et al., 2017). Dragojlovic and Einsiedel (2012) reported 305 
that more religious respondents are less supportive of synthetic biology. However, the 306 
influence of religiosity on people’s attitudes decreases when they have higher confidence in 307 
the institution of science. Among those less deferential towards scientific authority, higher-308 
level trust in scientists could positively affect people’s support for synthetic biology (Akin et 309 
al., 2017). These findings suggest that increased trust in scientists may improve the public 310 
acceptance of synthetic biology. 311 
The association between public attitudes towards synthetic biology and their demographic 312 
characteristics was also studied, such as gender and educational background (see Table 3). 313 
Men in the US perceived lower risks associated with synthetic biology in comparison to  314 
women (Mandel et al., 2008), a demographic difference which has  been reported for other 315 
technologies (Finucane, Slovic, Mertz, Flynn, & Satterfield, 2000). Finucane et al. (2000) 316 
attributed the “white male effect” to men’s perceiving themselves to be more involved in 317 
controlling and benefiting from technologies than women in the US. People with higher 318 
educational levels were reported as exhibiting a tendency to be more supportive of synthetic 319 
biology (Akin et al., 2017), as were students with natural science backgrounds, compared to 320 
those studying humanities and social sciences, the latter being an intuitive outcome given 321 
participants motivation and preferences  (Ineichen, Biller-Andorno, & Deplazes-Zemp, 322 
2017). The influence of educational level and gender on public attitudes, however, was 323 
sometimes not reported in relation to synthetic biology, in contrast to what has been found for 324 
GM  (Akin et al., 2017; Frewer, Howard, & Shepherd, 1996; Kahan, Braman, & Mandel, 325 
2009; Verdurme & Viaene, 2003). However, there is evidence that gender differences in 326 
public attitudes to GM disappear after the tangible benefits of specific GM foods  have been 327 
presented to participants  (Frewer et al., 1996), again implicating the importance of contexts 328 
when assessing attitudes, which may shape perceived perceptions of benefit associated with 329 
specific products or applications.  330 
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5. Public perceptions of synthetic biology-based applications in the agrifood sector 331 
Public attitudes often varied according to different applications of emerging technologies. A 332 
recent systematic review indicated that people hold more positive attitudes towards GM 333 
plants and their derivative products compared to attitudes towards GM animal products 334 
(Frewer et al., 2013). People are less accepting of GM animals if these are modified for food 335 
use rather than for medical reasons, with  medical applications possibly perceived to be more 336 
“necessary” than those related to food (Frewer, Coles, Houdebine, & Kleter, 2014). In the 337 
case of nanotechnology, medical and environmentally beneficial applications tended to be 338 
viewed as more accepted by consumers (Priest & Greenhalgh, 2011). Within the food 339 
domain, nanotechnology for developing food packaging is more likely to be supported than 340 
food products for consumption (Giles et al., 2015).  341 
The pattern of results for synthetic biology applied in the agrifood sector is not greatly 342 
different to other technological applications, although comparisons are made complex 343 
because of differences in study design across technologies. In the case of  synthetic biology, 344 
more positive perceptions were found to result among research participants after concrete 345 
examples of applications were introduced (Ineichen et al., 2017; Rakic, Wienand, Shaw, 346 
Nast, & Elger, 2017). People expressed more optimism about medical applications, such as 347 
synthetic microbes used for the production of medicine (Ineichen et al., 2017; Pauwels, 2013; 348 
Starkbaum, Braun, & Dabrock, 2015; Steurer, 2015), and disease treatment using engineered 349 
autologous cells (Rakic et al., 2017). However, concerns about unknown long-term impacts 350 
of such medicines on human health, unintended release of synthetic microbes, and economic 351 
interests were still raised. Environmental applications were more acceptable to participants 352 
than agricultural applications. Although released synthetic microbes are more uncontrollable 353 
regarding their reproduction and spread, participants still showed more support for those 354 
applied in pollutant sensing and bioremediation compared to GM maize (modified to faciliate 355 
reduced application of herbicides/insecticides) and rice (modified to increase levels of pro-356 
vitamin A) (Ineichen et al., 2017). As a result, synthetic biology-based applications for 357 
environmental enhancement (e.g. synthetic microbe as biosensors and for bioremediation) 358 
could be preferred by the public compared to those for crop improvement (e.g. productivity 359 
increase and reduced needs for inputs in agriculture) (see Table 1). 360 
Generally, people tend to express more negative attitudes to synthetic biology applied in 361 
agricultural and food production (Pauwels, 2013; Steurer, 2015). Synthetic organisms (e.g. 362 
virus, bacterium and insect), developed either for pest control or boosting plant growth, raised 363 
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concerns for research participants due to their uncontrollability, unknown long-term health 364 
impacts and potential for bioterroristic use (Steurer, 2015). It is notable that mosquitos 365 
engineered by synthetic gene-drive systems for facilitating the eradication of malaria were 366 
perceived to be highly uncontrollable, but people did not express strong opposition to this 367 
application (Hart Research Associates, 2013). Again this suggests that medical applications 368 
are perceived to be more “necessary” than agricultural applications (Starkbaum et al., 2015). 369 
Other agrifood applications, such as animals with accelerated growth and synthetic microbes 370 
applied to facilitate food production (e.g. production of food additive), were viewed more 371 
negatively by research participants (Hart Research Associates, 2013). This could potentially 372 
be related to consumers’ concerns about their unknown long-term impacts as well as 373 
perceived unnaturalness of the food production process (Román, Sánchez-Siles, & Siegrist, 374 
2017). A study by Dragojlovic and Einsiedel (2013) also indicated the negative influence of 375 
perceived unnaturalness on participant acceptance of synthetic yeast-based sweetener, in 376 
particular among participants who regard nature as sacred or spiritual.  377 
The evidence suggests that people’s attitudes appear to vary between different applications of 378 
synthetic biology, either across sectors or within the agrifood sector. Medical and 379 
environmental applications could be more acceptable than those applied in food and 380 
agricultural production. However, agrifood applications with tangible and desirable benefits 381 
may also be accepted, such as novel food products with health benefits (e.g. nutraceuticals), 382 
since they could evoke more positive perceptions compared with those delivering no health 383 
benefits. Application of synthetic biology for food packaging development may also be 384 
supported according to people’s preferences for nanotechnology applications (Giles et al., 385 
2015). So, of the listed agrifood applications in Table 1, the public may prefer those for 386 
environmental enhancement, producing healthy food products and food packaging to be 387 
developed and commercialised. These findings also imply that public perceptions and 388 
attitudes of synthetic biology are linked to attributes of specific applications, as is the case for 389 
GM and nanotechnology (Frewer et al., 2013; Giles et al., 2015). 390 
6. Discussion 391 
At present, there are no specific issues identified from existing research into public 392 
perceptions and attitudes  which distinguish synthetic biology from other enabling 393 
technologies, in terms of public perceptions and attitudes (Akin et al., 2017; Steurer, 2015). 394 
However, some issues uniquely associated with synthetic biology may need further 395 
consideration. For example, open-sourcing of synthetic biology improves accessibility of 396 
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technology development to non-professionals, which may increase risks in relation to both 397 
bioterror and bioerror. When applied as a bottom-up approach, ethical aspects become more 398 
prominent in societal discussions (Bedau et al., 2009). Therefore, it is important to study the 399 
influence of these two issues on public attitudes and associated governance practices by 400 
linking them to specific applications and other contexts. In addition, as more novel 401 
applications are being developed, ambiguities in regulation may occur, and improvement of 402 
regulation and governance is therefore needed. Taking the arsenic biosensor (where synthetic 403 
bacteria contained in a secure casing) as an example, the developers’ application for 404 
exemption from The Contained Use Directive (2009/41/EC)1 and The Deliberate Release 405 
Directive (2001/18/EC)2 was not approved in the European Union. This was because the 406 
application was technically “contained” but applied outside of a laboratory (European Food 407 
Safety Authority, 2015).  408 
A limited number of studies have identified factors that may affect public attitudes, such as 409 
perceptions of risks, benefits and ethical issues, trust in scientists, industry and government, 410 
and individuals’ socioeconomic, demographic and value attributes. Although findings in 411 
relation to the influence of individual socioeconomic and demographic characteristics as 412 
reported in the literature is somewhat inconsistent, ongoing research is required to assess how 413 
perceptions and attitudes in different demographic groups varies as this is required in order to 414 
develop targeted risk communication strategies (Frewer et al., 2013). Integrating findings of 415 
research on synthetic biology as well as GM and nanotechnology, participants’ perceptions 416 
and attitudes were linked to specific characteristics of applications, and they tended to hold 417 
more optimism after being informed of concrete benefits of applications. Metaphors such as 418 
“Playing God” and “creating life” were infrequently mentioned in the context of specific 419 
applications of synthetic biology, and perceived “unnaturalness” was only identified in food 420 
production (Dragojlovic & Einsiedel, 2013). These results suggest that, in common with 421 
other agri-technologies, risk and benefit perceptions will contribute in shaping public 422 
attitudes towards synthetic biology and its specific applications. Notably, these studies have 423 
tended to focus on synthetic biology per se rather than specific applications, and no research, 424 
so far, has investigated how trade-offs between benefits, risks and other issues are made by 425 
people during decision-making. Previous research showed that benefits of GM technology 426 
perceived by research participants are discounted (Siegrist & Sütterlin, 2016), and people’s 427 
                                                 
1 https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=celex%3A32009L0041 (accessed 6 May 2009). 
2 https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=celex%3A32001L0018 (accessed 12 Marth 2001). 
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risk and benefit perceptions of the same product could be different due to diverse personal 428 
characteristics (Hu et al., 2004). Individuals’ trade-offs between perceived benefits, risks and 429 
other issues in decisions-making are also heterogeneous regarding innovative food 430 
technology acceptance (Bearth & Siegrist, 2016). In other words, the role of different 431 
perceptions in determining public attitudes could be highly variable, and is affected by 432 
various contextual factors, such as type of technology, socio-demographic, cultural or 433 
geographical differences between participants, and even regional difference in legislation of 434 
studied food technology (Bearth & Siegrist, 2016; Costa-Font & Gil, 2009). To avoid 435 
unnecessary scares and encourage the acceptance of synthetic biology applied in the agrifood 436 
sector, public perceptions and their influence on people’s attitudes need to be investigated in 437 
the context of specific applications with concrete and tangible benefits  (Hansen, Holm, 438 
Frewer, Robinson, & Sandøe, 2003). Specifically, it is important to understand how people 439 
make trade-offs between their perceived benefits, risks and other issues of synthetic biology, 440 
together with contextual factors that impact the decision-making process. 441 
With respect to the public attitudes towards synthetic biology, social amplification of 442 
perceived risks does not seem to have arisen, as the media portrayal is, to date, relatively 443 
positive. There is also little evidence showing  an “inherent societal aversion” to synthetic 444 
biology as an enabling technology (Betten et al., 2018; Pauwels, 2009). While a number of 445 
agrifood applications have been identified as potentially preferred by the public for 446 
development, there is still a lack of relevant studies to support this in practice, which makes it 447 
difficult to more accurately predict public priorities and preferences from Table 1.  448 
This review suggests that the context in which synthetic biology is applied may be relevant to 449 
understanding which applications should be a priority for commercialisation technologies 450 
(Oliver, 2018). It is well established that context (including product type) effects people’s 451 
preferences and decision-making (Kahneman & Tversky, 2000). From moral perspective, 452 
Falk and Szech (2013) also have argued that individuals’ decision-making in relation to 453 
moral or ethical issues may differ in different contexts.  Context, or how the product of an 454 
enabling technology is perceived, is likely to vary between different applications and so 455 
merits investigation.  456 
The process of reviewing the literature also highlighted some problems in experimental 457 
design. Some studies over-emphasised the origins of genes, which is a defining characteristic 458 
of GM, rather than the attribute of synthetic biology applications (Amin et al., 2013; 459 
Dragojlovic & Einsiedel, 2013). Previous research suggested that people may perceive 460 
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different risks and benefits of the same food product based on affect heuristic and/or 461 
cognitive reasoning (Slovic, Finucane, Peters, & MacGregor, 2004). For unfamiliar GM 462 
foods, people’s risk and benefit perceptions are formed by more information and thus more 463 
cognitive reasoning dependent.  The affect heuristic, however, plays a more important role in 464 
people’s perceptions of foods that are perceived to be unfamiliar by them (Fischer & Frewer, 465 
2009). In other words, if the presentation of synthetic biology to the public  is framed 466 
primarily based on attributes of GM, people’s attitudes towards synthetic biology-based 467 
applications could be biased due to their affect heuristic irrelevant to GM products, in 468 
particular those who perceive a situation of information sufficiency. /Furthermore, when 469 
developing experimental information interventions, the introduction of synthetic biology 470 
should be clear, and selected examples of applications should be realistic rather than “blue 471 
sky ideas”.  472 
It is also notable that previous research on the factors which drive agrifood technology 473 
acceptance has tended to occur after societal rejection, delivering greater understanding of 474 
drivers of public rejection as opposed to acceptance (Frewer et al., 2014). In the case of 475 
synthetic biology, it is important to ensure societal and consumer engagement occurs 476 
throughout the research and development process. That is, as the technology evolves, a 477 
number of research questions need to be further answered prior to, and during, the 478 
commercialisation process associated with agrifood applications.  479 
• What are the public preferences for potential applications of synthetic biology in the 480 
agrifood sector? And what “features” or characteristics of products will align with 481 
societal preferences and priorities? 482 
• What influences peoples’ decisions about the acceptability or otherwise of specific 483 
applications of synthetic biology? Will factors such as “open sourcing” and 484 
perceptions that “life is being created” impact people’s decisions? 485 
• How can key stakeholders in synthetic biology development (including scientists, 486 
industries and policy makers) “fine tune” the development and commercialisation 487 
process in line with societal priorities and expectations? What information and 488 
knowledge needs to be exchanged with societal stakeholders, and how might this be 489 
achieved? 490 
7. Limitations of the research  491 
At present, and as has been noted, there is a limited literature available for review. Despite 492 
extrapolating from research into public attitudes of GM and nanotechnology, the authors have 493 
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been unable to further identify public priorities for development from the listed applications 494 
in Table 1. The lack of empirical research also impeded comparisons of attitudinal 495 
differences across regions and time. As a consequence, important research gaps have been 496 
identified, which, once filled, will benefit the development of commercialisation trajectories 497 
for applications within the agrifood sector, as well as the development of effective 498 
governance practices. 499 
8. Conclusions  500 
Synthetic biology has undergone considerable growth in recent years, with various potentially 501 
beneficial applications in the agrifood sector having been under development. However, the 502 
future commercialisation of these applications could be uncertain due to public risk 503 
perceptions and ethical concerns. Given the relatively positive media portrayal at the present, 504 
public attitudes appear to be uncrystallised. Also, people’s attitudes and perceptions are likely 505 
to vary according to traits of applications. For instance, the public are inclined to accept 506 
applications for environmental enhancement, healthy food production and food packaging 507 
development. However, current studies into public attitudes towards synthetic biology have 508 
focused more on the technology per se, but failed to contemplate application types, which has 509 
impeded further identification of public priorities from Table 1. This is also an important 510 
research gap which merits investigation as it guides “fine-tuning” characteristics of 511 
applications in particular those at critical development points and optimise the 512 
commercialisation process. Other contextual factors, in particular those affecting the impacts 513 
of perceptions on people’s acceptance or rejection of synthetic biology, should also be 514 
investigated. This information, together with the public priorities, could provide the basis for 515 
more effective public risk communication and regulatory mechanisms establishment, for 516 
example, in relation to identification and discussion of potential (socially prioritised) benefits 517 
in agrifood governance. In summary, better framing of synthetic biology needs to be 518 
developed for better conducting relevant research and effective public engagement. More 519 
studies into public responses to synthetic biology are also required, which may provide 520 
information for “fine tuning” technical researchers’ experiments, companies’ product design 521 
and commercialisation, and forming the basis for more effective regulation mechanisms. 522 
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Table 1. Applications of synthetic biology in the agrifood sector  
Area of application Host Traits/product Examples Stage  References 
Agriculture 
  
  
  
  
  
  
  
  
  
  
  
  
Crop improvement Plant Productivity increase  Improved carbon fixation in crops. Laboratory Bar-Even, Noor, Lewis, & Milo, 2010; 
Gonzalez-Esquer, Shubitowski, & Kerfeld, 2015. 
Plant Production of novel substance 
or increased content of 
existing substance 
 
Nutraceuticals such as carotenoid; Increased 
content of lignocellulose, oil, soluble sugar 
as bioenergy. 
Laboratory Fraser, Enfissi, & Bramley, 2009; Shih, Liang, & 
Loqué, 2016. 
Plant Reduced need for inputs into 
agriculture 
 
Engineered crops with reduced demands for 
inputs such as pesticide, water and nitrogen. 
Laboratory Abbas, Zafar, Khan, & Mukhtar, 2013; Park et 
al., 2015; Rogers & Oldroyd, 2014. 
Plant New ways of self-
incompatible crop breeding  
Diploid potato breeding. Laboratory, trial Ye et al., 2018. 
Microbe Biofertilizer or biopesticide 
production 
Provide biofertilizer or biopesticide through 
plant-microbe interaction. 
Laboratory, trial Farrar, Bryant, & Cope-Selby, 2014; Project 
Auxin from iGEM (http://2011.igem.org/Team: 
Imperial_College_London). 
Pest/crop disease control Microbe Biosensors 
 
Pathogen detection in plants and soil. Laboratory Damiati, Mhanna, Kodzius, & Ehmoser, 2018; 
Ostrov et al., 2017; Van Der Meer & Belkin, 
2010. 
Microbe Bio-insecticides Fusion protein toxic to certain insects. Laboratory Abbas et al., 2013. 
Microbe Synthetic microbe killing 
specific pests 
 
Synthetic virus/fungus targeting and killing 
specific pests 
Envisioned Inceoglu, Kamita, Hinton, Huang, Severson, 
Kang & Hammock, 2001. 
Insect Sterile pests with synthetic 
gene drive system 
Synthetic gene drive for sex-ratio distortion 
of certain pest group 
 
Laboratory, trial McFarlane, Whitelaw, & Lillico, 2017. 
Environmental enhancement Microbe Biosensors Pollutant test such as heavy metal. Laboratory, trial, 
commercial 
Joshi, Wang, Montgomery, Elfick, & French, 
2009; Kim, Jeong, & Lee, 2018. 
Microbe Bioremediation Bioremediation of metal, radionuclides and 
other substances. 
 
Laboratory, trial Marques, 2018; Tay, Nguyen, & Joshi, 2017. 
Microbe Tackling soil erosion Engineered bacteria for promoting root 
growth and protecting the soil from erosion. 
Laboratory, trial Project Auxin from iGEM 
(http://2011.igem.org/Team: 
Imperial_College_London). 
Microbe Biofuels Production of cellulosic ethanol, diesel, etc. Laboratory, trial, 
commercial 
Mascoma (http://www.mascoma.com); Solazyme 
(http://solazyme.com). 
Livestock management 
  
Microbe Biosensor and biotherapeutics 
 
Whole cell-mediated health monitoring and 
disease treatment  
Laboratory Krishnamurthy, Moore, Rajamani, & Panchal, 
2016; Slomovic, Pardee, & Collins, 2015; Sola-
Oladokun, Culligan, & Sleator, 2017. 
Microbe Function of facilitating feed 
processing  
Engineered microbe or enzyme for feed 
processing. 
Laboratory, trial, 
commercial 
Mascoma (http://www.mascoma.com); 
Metabolic Explorer SA (https://www.metabolic-
explorer.com). 
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Animals Animal breeding  Breeding of new lines depending on 
synthetic gene drive, genome editing, 
synthesised genes, etc.  
 
Envisioned Gonen et al., 2017; Bhat et al., 2017. 
Food  
  
  
  
  
  
Food products  Microbe, 
plant 
 
Novel foods Casein for milk production from yeast; Egg 
white from yeast. 
Laboratory, trial, 
commercial 
Perfeet Day (http://www.perfectdayfoods.com); 
Clara Foods (https://www.clarafoods.com). 
Microbe, 
plant 
Food additives Colorant and flavours (vanillin, raspberry 
ketone, Stevia et al); nutraceuticals 
(vitamins, carotenoid et al.). 
Laboratory, trial, 
commercial 
Evolva (https://www.evolva.com); Hanson et al., 
2018; Leonard et al., 2010; Nigam & Luke, 
2016; Prima et al., 2017; Wang, Zada, Wei, & 
Kim, 2017. 
Food processing Microbe Improved fermentation 
process 
Higher fermentation efficiency or better 
flavour products. 
Laboratory, trial, 
commercial 
Jagtap, Jadhav, Bapat, & Pretorius, 2017; Lee, 
Lloyd, Pretorius, & Borneman, 2016; Mays & 
Nair, 2018; iGEM Munich Team 
(http://synbio.info/display/synbio/ 
Beer+with+caffeine). 
Food safety diagnosis Microbe Biosensors Food toxin, pathogen, parasite or other 
substance detection. 
Laboratory, trial Sample6 (https://www.sample6.com); De Mora 
et al., 2011; Webb et al., 2016. 
Food waste processing Microbe Waste degradation and useful 
substance extraction 
Engineered microbe for phosphorus recovery 
from food waste. 
 
Laboratory, trial Lakhundi, 2012; Tarayre et al., 2016. 
Food packaging Microbe Material production Biodegradable material such as biopolymer. Laboratory, trial, 
commercial 
Jung, Kim, Park, & Lee, 2010; Yield10 
Bioscience (https://www.yield10bio.com); 
Bioamber (https://www.bio-amber.com); GC 
Innovation America 
(https://www.gcinnovationamerica.com). 
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Table 2. Analysis of media portrayal about synthetic biology 
Origins of reportage Search method Sample size Period of media 
reportage 
Data analysis Research focus Major findings References 
US and Europe “Synthetic biology" was searched in 
major US newspapers based on 
LexisNexis; multilingual search for 
the term "synthetic biology" in 
major European newspapers 
(articles in English, French, Dutch, 
German, Spanish and Italian). 
309 from US; 
841 from Europe. 
January 2003 to 
December 2011 
Not reported  Change in the amount of 
coverage in relation to 
synthetic biology; key 
issues mentioned in media. 
Coverage of synthetic biology in press 
grew in the 2008–2011 period when 
compared with the 2003–2008 period; A 
significant increase occurred in particular  
of coverage was seen in 2008 and 2010; 
energy and health applications were 
reported as benefits; the media reported 
concerns focused om biosafety, 
biosecurity and ethics. 
 
 
Pauwels & Ifrim, 2008; 
Pauwels et al., 2012 
Austria, Germany and 
Switzerland 
Terms such as "synthetic biology", 
"artificial life", "designer AND 
organism", "minimal organism", 
"minimal genome", "bioengineer", 
"biomachine", "biobrick", "artificial 
DNA", "artificial proteins", 
"artemisinin", "biorobot", "synthetic 
bacterium", "synthetic virus" and 
"DNA AND synthesis" (German 
equivalents) were used to search the 
media database APAdefacto and 
Google Alerts. 
 
 
233 in German January 2004 to 
December 2009 
Qualitative and 
quantitative 
content analysis  
Motives?? Synthetic 
biology topics covered by 
media coverage; framing 
of synthetic biology; 
related risks, benefits and 
applications. 
Engineering metaphors are more 
prominent in media coverage; a new 
aspect of “playfulness” was identified in 
coverage of synthetic biology compared 
with GM; ambiguities exist between the 
description of synthetic biology and GM. 
Gschmeidler & Seiringer, 2012 
English and German 
speaking countries 
GBI-Genios database was searched 
using the term "Synthetische 
Biologie"; LexisNexis database was 
searched using "synthetic biology". 
10831 in English;  
1036 in German. 
January 2004 to 
December 2015 
Qualitative and 
quantitative  
content analysis 
Framing of, and metaphors 
for, synthetic biology 
discussed in the media 
discourse. 
A substantially higher frequency of 
engineering and IT related metaphors were  
identified in media coverage compared to 
religio-cultural expressions, such as 
"playing God" or "creating life". 
 
 
Braun et al., 2018 
US News articles were collected from 
The New York Times using the 
term "synthetic biology". 
32  January 2005 to  
July 2015 
Qualitative and 
quantitative  
content analysis 
Discussion of ethical 
issues; comparison of 
"synthetic biology" and 
genetic modification 
discussed in media reports 
or stories. 
 
Ambiguity about potential ethical issues 
and the relation between synthetic biology 
and genetic engineering were identified, 
which might act as a barrier public 
engagement. 
Giordano & Chung, 2018 
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Denmark, Finland, 
Norway and Sweden 
Terms such as "Artemisinin", 
"artificial life", "synthetic life", 
"bio-brick", "bioterrorism", "DNA 
synthesis", "iGEM", "synthetic 
biology", inter alia (equivalents in  
four national languages) as well as 
names of renowned scientists were 
used for searching in newspapers’ 
archives and through the media 
databases Mediearkivet, Infomedia, 
and PressText. 
 
 
146  January 2009 to 
December 2014 
Qualitative and 
quantitative 
content analysis 
The tone of the articles 
analysed was assessed by 
the authors according to 
their interpretation of the 
narrative provided by the 
story; other issues assessed 
included the synthetic 
biology topics covered by 
media coverage; framing 
of synthetic biology; 
metaphors used for 
synthetic biology.  
 
Potential benefits of synthetic biology 
were highlighted; the media portrayal of 
synthetic biology tended to be very 
positive; minor risks were mentioned 
mainly related to bioterror and bioerror; 
public involvement was rarely suggested 
as relevant. 
Ancillotti et al., 2017 
Sweden and Italy  Terms such as "Artemisinin", 
"artificial life", "synthetic life", 
"bio-brick", "bioterrorism", "DNA 
synthesis", "iGEM", "synthetic 
biology", inter alia (Swedish and 
Italian equivalents) as well as 
names of renowned scientists were 
used for searching in newspapers’ 
archives and through the media 
databases Mediearkivet and 
PressText. 
 
 
131  January 2009 to 
December 2013 
Qualitative and 
quantitative  
content analysis 
The tone of the articles 
analysed was assessed by 
the authors according to 
their interpretation of the 
narrative provided by the 
story; other issues assessed 
included the synthetic 
biology topics of media 
coverage; Motives??? 
framing of synthetic 
biology; metaphors used 
for synthetic biology; 
issues related to 
technology oversight or 
public interest or public 
engagement. 
 
The portrayal was very positive, 
describing synthetic biology as a 
“biotechnology with great benefits and 
minor risks”; risks were mainly related to 
bioterror and bioerror; coverage of 
synthetic biology was more “event-
driven”, i.e. linked to novel developments 
etc.  rather than about the technology per 
se; public involvement was rarely 
suggested as relevant. 
Ancillotti & Eriksson, 2015 
Netherlands Terms such as "synthetic biology", 
"synthetic cell", "synthetic 
genome", "minimal genome", 
"iGEM", inter alia (Dutch 
equivalents) were used to search for 
newspaper articles in LexisNexis 
database. 
261 January 2000 to 
November 2016 
Qualitative and 
quantitative  
content analysis 
The tone of the articles 
analysed was assessed by 
the authors according to 
their interpretation of the 
narrative  provided by the 
story; other issues analysed 
included the synthetic 
biology; motives??? topics 
of media coverage; 
applications, risks, and 
ethical issues; and the use 
of metaphors in articles. 
Dutch newspapers paid limited attention to 
synthetic biology; when it occurred, the  
coverage was more event-driven; The 
Dutch press tended to be neutral or 
positive about synthetic biology; 
healthcare and environmental applications 
were discussed  in terms of potential 
benefits rather than in terms of risk and 
ethical issues; engineering related 
metaphors were more frequently used 
which potentially suggested that the 
technology is "controllable". 
 
 
Borgers, 2017 
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Table 3. Literature focused on public perceptions of , and attitudes towards, synthetic biology    
Research method            Data analysis  Participants Sample size  Demographic 
differences assessed  
Information provided 
to participants 
Participants' perceptions and attitudes References 
Observation on 
stakeholder discussion 
Discourse analysis Prospective politicians and 
synthetic biologists from 
Netherlands  
 
Not reported Not assessed General introduction about 
synthetic biology and the 
current academic 
discussion.  Information 
about specific applications 
was not presented. 
 
The issues discussed focused on the need for synthetic 
biology and  participant concerns about deliberate 
release, moral boundaries and political control. 
Rerimassie, 2016 
Focus group Thematic analysis Dutch citizens  46 (8 groups)  Not assessed Although both a general 
introduction and 
applications (in relation to 
health, environment and 
food) were provided, the 
paper analysed, 
participants’ opinions 
about the technology per 
se and its development 
rather than upon different 
applications. 
 
Participants discussed concerns about human health 
effects, the uncontrollability of applications, and ethical 
issues, although the results indicate that people are not 
inherently against or for synthetic biology. 
 
Betten et al., 2018 
Citizen panel  Content analysis; 
frame analysis 
Austrian citizens  67 (8 panels)  Not assessed A general introduction and 
examples of applications 
were presented to 
participants (including 
synthetic yeast-based 
artemisinin, a modified 
organism for pest control, 
and synthetic algae-based 
biofuel) were provided to 
participants for discussion.  
 
The anti-malaria drug production presented invoked 
concerns about potential long-term health effects and 
potential for bioerror, but the application was still 
assessed as “acceptable” to study participants However, 
participants tended to oppose the use of synthetic 
organisms for pest control due to perceived 
uncontrollability, potential for long-term impacts and 
potential for bioterror; some participants expressed 
distrust in scientists, industries and authorities; "playing 
God" and unnaturalness were not mentioned by 
participants. 
 
Steurer, 2015 
Focus group Descriptive and 
inferential statistics 
Austrian citizens  49 (8 groups) Not assessed A general introduction 
about synthetic biology 
developed from the 
available media coverage 
was provided without 
discussion  of specific 
applications. 
Concerns were mainly focused on bioterror and 
potential environmental and health impacts; participants 
expressed skepticism about manipulating human and 
animal cells; values related to a group's identity may 
collectively affect their examination of technologies 
such as synthetic biology. 
 
 Kronberger et al., 
2012 
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Interview Thematic analysis Stable patients in  
German-speaking part  
of Switzerland  
36 Not assessed A general introduction and 
information about specific 
applications (engineered 
autologous cells for disease 
treatment) were provided. 
 
Participants expressed concerns about "playing God" 
before being provided with information about specific 
applications; their attitudes became more positive after 
learning about specific applications. 
 
Rakic et al., 2017 
Observation on 
stakeholder discussion 
Not reported Non-synthetic biologists in 
disciplines (e.g. social 
sciences, philosophy and 
biology) mainly from 
Europe  
 
23 Not assessed The paper does not report 
on whether any 
information has been 
provided to participants, 
and there is no presentation 
of about specific 
applications.  
 
Participants (stakeholders)  exhibited unrealistic 
expectations of what synthetic biology can deliver, at 
the same time expressing fears about the potential for 
bioterror; participants' attitudes depend on their values 
and interests, in line with their stakeholder interests.  
Verseux et al., 
2016 
Observation on 
stakeholder discussion 
Not reported Scientists, members of 
NGOs, funding agencies, 
and industry mainly in 
Europe and America 
 
124 Not assessed A general introduction to  
synthetic biology was 
provided without 
discussion of specific 
applications   
 
"The creation of life" was  expressed as a concern by 
the participants; participants were  also concerned about 
potential threats associated with biohackers who 
conduct biological experiments individually or in small 
organizations. 
Schmidt et al., 
2008 
Focus group Grounded theory German and Austrian  
citizens  
69 (9 groups)  Age had no effects on the 
discussions about synthetic 
biology; groups with 
higher educational level 
focused more on the 
benefits and regulation of 
synthetic biology 
compared to  those with 
lower educational level.  
 
A general introduction to 
synthetic biology was 
presented, together with 
information about specific 
applications (including 
synthetic yeast-based 
artemisinin, a modified 
organism for pest control 
and synthetic algae-based 
biofuel).   
 
Synthetic organisms intended for medical production 
are considered to be more beneficial and necessary than 
those developed for pest control and energy; 
participants are more concerned about bioerror than 
bioterror; in relation to ethical concerns, equitable 
benefit distribution across different beneficiary was the 
issue most discussed. 
Starkbaum et al., 
2015 
Survey and focus  
group afterwards 
Descriptive statistics 
for survey data; not 
reported for focus 
group data 
American citizens 3,004 surveys 
and 8 focus 
groups  
Not assessed A general introduction to 
synthetic biology was 
presented, together with 
information about specific 
applications (including a 
synthetic virus for vaccine 
production, synthetic 
yeast-based artemisinin 
and altered pigs and cows 
with accelerated growth).  
 
Medical and biofuel applications were  accepted by 
most participants; Applications which facilitated animal 
growth were less acceptable to participants than 
medical production using animals; potential long-term 
effects on human health and environment were a focus 
of concern. 
 
Pauwels, 2013 
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Survey Descriptive and 
inferential statistics 
American citizens 1,500 An analysis of 
demographic differences 
indicated that Europeans, 
males, or participants with 
higher incomes perceived 
synthetic biology to be less 
risky; no significant 
attitudinal differences were 
associated with education 
level. 
 
A general introduction to 
synthetic biology was 
provided, but no 
information about specific 
applications was included. 
 
Over 80% respondents reported knowing  little about 
synthetic biology; the majority of participants perceived 
benefits to be more relevant than risks; people's risk 
perceptions were, however, associated with their 
cultural dispositions. 
Kahan et al., 
2009  
Survey Descriptive statistics American citizens 804 An analysis of 
demographic differences 
indicated that Europeans, 
males, or participants with 
higher incomes, higher 
educational level or higher 
incomes tended to be more 
supportive of synthetic 
biology. 
 
A general introduction to 
synthetic biology was 
provided, together with 
information about specific 
applications (altered 
mosquito for disease 
control, and a synthetic 
microbe for facilitating 
crop growth or food 
additive production). 
 
People trusted scientists more than industry and 
government; concerns were expressed about the 
enabling technology in relation to its potential capacity 
to create harmful things, the “creation of artificial life” 
and potential for adverse human health effects; medical 
applications were more acceptable to  participants than 
agrifood applications. 
 
Hart Research 
Associates, 2013 
Survey Descriptive and 
inferential statistics 
Canadian citizens 1,201 Not assessed A general introduction to 
synthetic biology was 
provided, together with 
information about a 
specific application 
(synthetic yeast-based food 
additive).  
 
Perceived unnaturalness reduced people's acceptance of 
sweetener production using synthetic yeast. 
 
Dragojlovic & 
Einsiedel, 2013 
Survey Descriptive and 
inferential statistics 
People from 32 European 
countries 
15,588 Not assessed A general introduction to  
synthetic biology was 
provided, but no 
information about specific 
applications was included.  
 
Most participants’ attitudes towards synthetic biology 
tended to be supportive or neutral; belief in God is 
associated with participants’  opposition to synthetic 
biology. 
 
Dragojlovic & 
Einsiedel, 2012 
Survey Descriptive and 
inferential statistics 
University students in 
Switzerland  
1,474 Female students perceived 
higher risks to be 
associated with synthetic 
biology and its 
applications; students in 
the humanities and social 
sciences perceived higher 
risks and lower benefits to 
be associated with 
synthetic biology than 
those in natural sciences. 
 
A general introduction to 
synthetic biology was 
provided, together with 
information about specific 
applications (a synthetic 
microbe for pollutant 
sensing, and land 
bioremediation). 
 
Participants showed more support for medical and 
environmental applications of synthetic biology than for 
GM crops; synthetic biology as an enabling technology 
is more accepted than GM, but less than 
nanotechnology. 
Ineichen et al., 
2017 
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Survey Descriptive and 
inferential statistics 
American citizens 1,771 Participants with higher 
educational level are 
supportive of synthetic 
biology; no significant 
attitudinal difference was 
found in terms of gender, 
income and age. 
 
A general introduction to 
synthetic biology was 
provided, but no 
information about specific 
applications was included. 
A range of factors influence people's attitudes towards 
synthetic biology. These include risk perceptions 
(reduced acceptance), benefit perceptions, (increased 
acceptance) higher trust in scientists (increased 
acceptance), deference to science (increased 
acceptance), educational level (increased acceptance) 
and greater religiosity (reduced acceptance).  
Akin et al., 2017 
Survey Descriptive and 
inferential statistics 
Indonesian students 
majoring in life science  
50 Not assessed A general introduction to 
synthetic biology was 
provided, which also 
addressed its potential for 
protecting biodiversity and 
developing healthcare 
products. However,  no 
specific applications were 
presented. 
 
Participants perceived both benefits and risks to be 
associated with synthetic biology; participants’  
attitudes varied between  different applications; in 
particular respondents' showed optimism about 
potential applications of synthetic biology in 
biodiversity conservation. 
 
Kemal, 2018 
 
 
 
 
